Skip to Content


In the US, Rasagiline (rasagiline systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of Parkinson's disease

Inhibitor of monoamin oxidase type B (MAO-B)

Chemical Names



Foreign Names

  • Rasagilinum (Latin)
  • Rasagilin (German)
  • Rasagiline (French)
  • Rasagilina (Spanish)

Generic Names

  • Rasagiline (OS: USAN)
  • Rasagiline Mesylate (OS: USAN)
  • AGN-1135 (IS)
  • Rasagiline methanesulfonate (IS)
  • TVP 1012 (IS: Teva)
  • TVP-101 (IS)

Brand Names

  • Azilect
    Lundbeck, Denmark; Lundbeck, Latvia; Lundbeck, Turkey; TEVA, Russian Federation
  • Menuix
    Pharma Investi, Chile
  • Parkintreat
    Inspire Ph, Egypt
  • Rasax
    AstraZeneca, Argentina
  • Agilect
    Teva, United States
  • Azilect
    Lundbeck, Australia; Lundbeck, Belgium; Lundbeck, Switzerland; Lundbeck, Spain; Lundbeck, Finland; Lundbeck, France; Lundbeck, Croatia (Hrvatska); Lundbeck, Ireland; Lundbeck, Sweden; Lundbeck, South Africa; Lundbeck Italia, Italy; Teva, Austria; Teva, Czech Republic; Teva, Greece; Teva, Hungary; Teva, Israel; Teva, Iceland; Teva, Lithuania; Teva, Netherlands; Teva, Norway; Teva, Romania; Teva, Serbia; Teva, Slovenia; Teva Canada Innovation, Canada; Teva Mexico, Mexico; Teva Pharma, Germany; Teva Pharma, Portugal; Teva Pharmaceuticals, United Kingdom
  • Elbrus
    Roemmers, Argentina
  • Menuix
    Roemmers Centroamérica, Guatemala; Roemmers Centroamérica, Honduras; Roemmers Centroamérica, Nicaragua; Roemmers Centroamérica, Panama; Roemmers Centroamérica, El Salvador
  • Rasagilina Richet
    Richet, Argentina

International Drug Name Search


ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.